Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Pretreatment for Bariatric Surgery
NCT02417103Phase 3Terminated
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Dec 2011
- Primary completion
- Sep 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in obesity, sponsored by University Medical Center Hamburg-Eppendorf. Started Dec 2011; status: terminated.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02417103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02417103.